Last month Bovie dealt its core business, including the Bovie brand, to Symmetry Surgical for $97 million. The all-cash sale augured a pivot for Clearwater, Fla.-based Bovie toward the cosmetic surgery market with its J-Plasma and Renuvion brands.
Today Bovie said it expects to post net losses of -$12.7 million to -$12.3 million on sales of $15.2 million to $15.6 million.
The news sent BVX shares down -5.4% to $5.85 apiece today in pre-market trading.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.